Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002355181 | SCV002622776 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-06-06 | criteria provided, single submitter | clinical testing | The c.38_68del31 pathogenic mutation, located in coding exon 1 of the CDKN2A gene, results from a deletion of 31 nucleotides at nucleotide positions 38 to 68, causing a translational frameshift with a predicted alternate stop codon (p.A13Vfs*3). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |